Cancer clinical trials in the region Grand Est
222 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Phase 1 / Phase 2
Kidney cancer
#NCT07049926
#2024-516437-12-00
Clear cell carcinoma
Locally Advanced
Metastatic
None
Immunotherapy
Systemic Treatment-Naive
Institut de Cancérologie de Lorraine - Alexis Vautrin (Vandœuvre-lès-Nancy)
Merck Sharp & Dohme LLC
Phase 1 / Phase 2
Lung cancer
#NCT04585750
#2023-504251-27-00
Locally Advanced
Metastatic
TP53
1
2
3 or more
KRAS G12C
KRAS non G12C
Systemic Treatment-Naive
Institut de Cancérologie de Lorraine - Alexis Vautrin (Vandœuvre-lès-Nancy), ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg)
PMV Pharmaceuticals, Inc
Phase 1 / Phase 2
Breast cancer
#NCT04585750
#2023-504251-27-00
Locally Advanced
Metastatic
TP53
1
2
3 or more
KRAS G12C
KRAS non G12C
Systemic Treatment-Naive
Institut de Cancérologie de Lorraine - Alexis Vautrin (Vandœuvre-lès-Nancy), ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg)
PMV Pharmaceuticals, Inc
Phase 1 / Phase 2
Endometrial cancer
#NCT04585750
#2023-504251-27-00
Locally Advanced
Metastatic
TP53
1
2
3 or more
KRAS G12C
KRAS non G12C
Systemic Treatment-Naive
Institut de Cancérologie de Lorraine - Alexis Vautrin (Vandœuvre-lès-Nancy), ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg)
PMV Pharmaceuticals, Inc
Phase 1 / Phase 2
Bladder / Urinary Tract / Urethral cancer
#NCT04585750
#2023-504251-27-00
Locally Advanced
Metastatic
TP53
1
2
3 or more
KRAS G12C
KRAS non G12C
Systemic Treatment-Naive
Institut de Cancérologie de Lorraine - Alexis Vautrin (Vandœuvre-lès-Nancy), ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg)
PMV Pharmaceuticals, Inc
Phase 1 / Phase 2
Prostate cancer
#NCT04585750
#2023-504251-27-00
Metastatic Castration-resistant
TP53
1
2
3 or more
KRAS G12C
KRAS non G12C
Systemic Treatment-Naive
Institut de Cancérologie de Lorraine - Alexis Vautrin (Vandœuvre-lès-Nancy), ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg)
PMV Pharmaceuticals, Inc
Phase 1 / Phase 2
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Stomach and esophageal cancer
#NCT04585750
#2023-504251-27-00
Locally Advanced
Metastatic
TP53
1
2
3 or more
KRAS G12C
KRAS non G12C
Systemic Treatment-Naive
Institut de Cancérologie de Lorraine - Alexis Vautrin (Vandœuvre-lès-Nancy), ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg)
PMV Pharmaceuticals, Inc
Phase 1 / Phase 2
Bladder / Urinary Tract / Urethral cancer
#NCT05706129
#2023-504254-35-00
Urothelial carcinoma
Locally Advanced
Metastatic
1
2
3 or more
Immunotherapy
Chemotherapy
Antibody Drug Conjugates (ADC)
Systemic Treatment-Naive
CHRU de Nancy - Hôpitaux de Brabois (Vandœuvre-lès-Nancy)
Debiopharm International SA
Phase 1 / Phase 2
Prostate cancer
#NCT04104776
#2023-508002-20-00
Metastatic Castration-resistant
1
2
3 or more
Chemotherapy
Hormone therapy
Systemic Treatment-Naive
ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg)
Constellation Pharmaceutique
Phase 1 / Phase 2
Breast cancer
Lung cancer
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Bladder / Urinary Tract / Urethral cancer
Stomach and esophageal cancer
#NCT04104776
#2023-508002-20-00
Urothelial carcinoma
Locally Advanced
Metastatic
ARID1A
1
2
3 or more
Systemic Treatment-Naive
ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg)
Constellation Pharmaceutique